(MedPage Today) — Two analyses suggested that non-medical (illicit) gabapentin use persisted in recent years as patterns in prescribing shifted.
The first analysis, led by Sara Karami, PhD, MPH, of the FDA’s Center for Drug Evaluation and Research…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
